GlassScriptPhysician profile
Andrea Walter
NPI 1457330417
$296.53
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.10 · 2020: $118 · 2021: $106 · 2022: $57.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $61.55 | 2020-2022 | |
| Alkermes, INC. | $59.21 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $42.31 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $33.18 | 2021 | |
| Neos Therapeutics, LP | $29.26 | 2020 | |
| Lundbeck LLC | $14.99 | 2020 | |
| Bausch Health US, LLC | $14.84 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.61 | 2020 | |
| Indivior INC. | $14.10 | 2019 | |
| Neuronetics, INC. | $12.48 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.